Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global epidemiology of epithelial ovarian cancer
Penelope M. Webb, Susan J. Jordan
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 5, pp. 389-400
Closed Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Extracellular vesicles display distinct glycosignatures in high-grade serous ovarian carcinoma
Kristina Mae Bienes, Akira Yokoi, Masami Kitagawa, et al.
BBA Advances (2025) Vol. 7, pp. 100140-100140
Open Access | Times Cited: 1
Exploring Strategies to Prevent and Treat Ovarian Cancer in Terms of Oxidative Stress and Antioxidants
Yanru Long, Houhui Shi, Jiatian Ye, et al.
Antioxidants (2025) Vol. 14, Iss. 1, pp. 114-114
Open Access | Times Cited: 1
T cell exhaustion and senescence for ovarian cancer immunotherapy
Jiao Zhao, Zhongmiao Wang, Yingying Tian, et al.
Seminars in Cancer Biology (2024) Vol. 104-105, pp. 1-15
Closed Access | Times Cited: 8
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
Eleonora Ghisoni, Matteo Morotti, Apostolos Sarivalasis, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8
Clinicopathological and prognostic factor analyses of primary fallopian tube carcinoma and high-grade serous ovarian cancer: a single-institution retrospective study
Mengyan Tu, Xueyan Gao, Tianchen Guo, et al.
World Journal of Surgical Oncology (2025) Vol. 23, Iss. 1
Open Access
Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021
Wenhui Ren, Xiangyu Guo, Zheng Liu, et al.
Cancer (2025) Vol. 131, Iss. 2
Open Access
Evaluating ovarian cancer risk-reducing salpingectomy acceptance: a survey
Alexandra Lukey, Ramlogan Sowamber, David G. Huntsman, et al.
Cancer Research Communications (2025)
Open Access
The emerging landscape of small nucleolar RNA host gene 10 in cancer mechanistic insights and clinical relevance
Jingyu Zhu, Zhongyu Jian, Fang-Teng Liu, et al.
Cellular Signalling (2025) Vol. 127, pp. 111590-111590
Closed Access
Harnessing Natural Saponins: Advancements in Mitochondrial Dysfunction and Therapeutic Applications
Hongmei Liu, Huan Wang, Xinyu Lin, et al.
Phytomedicine (2025) Vol. 138, pp. 156383-156383
Closed Access
Immunotherapy in Recurrent Ovarian Cancer
Keyao Chen, Jingjing Wang, Meng Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 168-168
Open Access
Characterizing tumor biology and immune microenvironment in high-grade serous ovarian cancer via single-cell RNA sequencing: insights for targeted and personalized immunotherapy strategies
Fu Zhao, Xiaojing Jiang, Yumeng Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Immune evasion in ovarian cancer: implications for immunotherapy and emerging treatments
Romi Gupta, Raj Kumar, Courtney A. Penn, et al.
Trends in Immunology (2025)
Closed Access
Novel factors of cisplatin resistance in epithelial ovarian tumours
Pavol Harvanik, Martina Šemeláková, Zuzana Solárová, et al.
Advances in Medical Sciences (2025)
Closed Access
DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway
Hui Wang, Shen Luo, Yue Yin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Dietary protein intake and PM2.5 on ovarian cancer survival: A prospective cohort study
He-Li Xu, Yifan Wei, Qi Bao, et al.
Ecotoxicology and Environmental Safety (2025), pp. 117798-117798
Open Access
Long Non-Coding RNAs in Ovarian Cancer: Mechanistic Insights and Clinical Applications
Sneha Basu, Revathy Nadhan, Danny N. Dhanasekaran
Cancers (2025) Vol. 17, Iss. 3, pp. 472-472
Open Access
Innovative and future approaches for ovarian cancer detection and evaluation: a comprehensive review
Fomukong Tasinda Raphael, Simon Nabirye
Asia-Pacific Journal of Oncology (2025), pp. 18-26
Closed Access
Systematic Pelvic and Paraaortic Lymph Node Dissection in Advanced Ovarian Cancer—Technical Aspects and Current Evidence-Based Data for Clinical Decision-Making
Traian Dumitrașcu
Surgical Techniques Development (2025) Vol. 14, Iss. 1, pp. 4-4
Open Access
Highly integrated and compact transduction strategy for multidimensional sensing: Near infrared light mediated transmission of optical, electrical and visual signals for ovarian cancer marker assay
Shupei Zhang, Yitian Huang, Lihong Gao, et al.
Biosensors and Bioelectronics (2025), pp. 117224-117224
Closed Access
Development of machine learning prognostic models for overall survival of epithelial ovarian cancer patients: a seer-based study
Jianing Fan, Yu Jiang, Xinyan Wang, et al.
Expert Review of Anticancer Therapy (2025)
Closed Access
PLIN2 Promotes Lipid Accumulation in Ascites‐Associated Macrophages and Ovarian Cancer Progression by HIF1α/SPP1 Signaling
Hui Luo, Xiaoling She, Yubo Zhang, et al.
Advanced Science (2025)
Open Access
The active components and potential mechanisms of Li-Chong-Xiao-Zhen granules in the treatment of ovarian cancer: An integrated metabolomics, proteomics, network pharmacology and experimental validation
Yiliu Chen, Rina Su, Guilin Hu, et al.
Journal of Ethnopharmacology (2025), pp. 119474-119474
Closed Access
Exploring the causal associations of the gut microbiota and plasma metabolites with ovarian cancer: an approach of mendelian randomization analysis combined with network pharmacology and molecular docking
Junfeng Guo, Chen Wang, He Li, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
Identifying prognostic biomarkers and immune interactions in ovarian cancer associated with perfluorooctanoic acid exposure: Insights from comparative toxicogenomics and molecular docking studies
Jianing Li, Xiao-Tian Bian, Caixia Zhang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117831-117831
Open Access
Page 1 - Next Page

Scroll to top